"Raynaud Disease" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An idiopathic vascular disorder characterized by bilateral Raynaud phenomenon, the abrupt onset of digital paleness or CYANOSIS in response to cold exposure or stress.
Descriptor ID |
D011928
|
MeSH Number(s) |
C14.907.617.812
|
Concept/Terms |
Raynaud Disease- Raynaud Disease
- Cold Fingers, Hereditary
- Raynaud's Disease
- Raynauds Disease
|
Below are MeSH descriptors whose meaning is more general than "Raynaud Disease".
Below are MeSH descriptors whose meaning is more specific than "Raynaud Disease".
This graph shows the total number of publications written about "Raynaud Disease" by people in this website by year, and whether "Raynaud Disease" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1996 | 0 | 1 | 1 |
2015 | 1 | 1 | 2 |
2016 | 1 | 0 | 1 |
2017 | 7 | 3 | 10 |
2018 | 5 | 4 | 9 |
2019 | 4 | 0 | 4 |
2020 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Raynaud Disease" by people in Profiles.
-
Case Report: Systemic Sclerosis After Covid-19 Infection. Front Immunol. 2021; 12:686699.
-
Cardiovascular, hematological and neurosensory impact of COVID-19 and variants. Eur Rev Med Pharmacol Sci. 2021 04; 25(8):3350-3364.
-
A strange case of severe but fleeting hypoxemia in patient with COVID-19 infection: maybe virus-induced pulmonary Raynaud's phenomenon? Monaldi Arch Chest Dis. 2021 Mar 05; 91(2).
-
Incidence, Characteristics, Laboratory Findings and Outcomes in Acro-Ischemia in COVID-19 Patients. Vasc Health Risk Manag. 2020; 16:467-478.
-
In systemic sclerosis patients the anxiety disorder and Raynaud's phenomenon are increased during lock down period for COVID-19 pandemic. Intern Emerg Med. 2021 Jun; 16(4):1095-1096.
-
Covid-19 overlapping with systemic sclerosis. Rev Soc Bras Med Trop. 2020; 53:e20200450.
-
Impact of the COVID-19 outbreak on an Italian cohort of systemic sclerosis patients. Scand J Rheumatol. 2020 11; 49(6):505-506.
-
Management of mild, primary Raynaud Syndrome: supplementation with Pycnogenol®. Minerva Cardioangiol. 2019 Oct; 67(5):392-398.
-
The Vessels Contribute to Fibrosis in Systemic Sclerosis. Isr Med Assoc J. 2019 Jul; 21(7):471-474.
-
A new avenue in the pathogenesis of systemic sclerosis: the molecular interface between the endothelial and the nervous systems. Clin Exp Rheumatol. 2019 Jul-Aug; 37 Suppl 119(4):133-140.